Results 71 to 80 of about 5,515 (141)

Evaluation of Clinical outcomes of Generic versus Reference Ivabradine in Heart Failure Patients

Archives of Pharmaceutical Sciences Ain Shams University, 2020
Economic benefits associated with usage of generic drugs have been suggested to increase patients’ adherence to their medications and to improve patients’ health outcomes.
Hadeer Eid, Hazem Khorshid, Ahmed Elsherif, Ebtissam Darweesh, Nagwa Ali Sabri, Naglaa Bazan   +5 more
doaj  

Risk-benefit assessment of ivabradine in the treatment of chronic heart failure

Drug, Healthcare and Patient Safety, 2014
Irmina Urbanek, Krzysztof Kaczmarek, Iwona Cygankiewicz, Pawel PtaszynskiDepartment of Electrocardiology, Chair of Cardiology and Cardiosurgery, Medical University, Lodz, PolandAbstract: Heart rate is not only a major risk marker in heart failure but ...
Urbanek I, Kaczmarek K, Cygankiewicz I, Ptaszynski P   +3 more
doaj  

Ivabradine for Incessant Atrial Tachycardia in a 1-Year-Old Child After Tetralogy of Fallot Repair

Case Reports in Cardiology
Discussion: Ivabradine may be an option for incessant atrial tachycardia in pediatric patients. Although most tachyarrhythmias following TOF repair occur due to a reentry mechanism, focal mechanisms can also occur, suggested by timing, gradual ...
Haikal Balweel, Rubiana Sukardi, Eva Miranda Marwali, Rifqi Rizkani Eri, Novaro Adeneur Tafriend, Agus Harsoyo   +5 more
doaj   +1 more source

Comparison of endothelial function in patients with Stage I-II arterial hypertension and stable angina, receiving various bradycardic agents and perindopril

Кардиоваскулярная терапия и профилактика, 1970
Aim. To compare endothelial function in patients with Stage I-II arterial hypertension (AH) and Functional Class (FC) II stable angina, receiving either beta-adrenoblocker (metoprolol tartrate) or If channel inhibitor (ivabradine), combined with ...
L. L. Kirichenko, A. N. Golosova, S. V. Gatsura, A. P. Korolev, K. V. Ovsyannikov, P. V. Struchkov   +5 more
doaj  

Cardiac drug potential: exploring individual and combined cardiac drugs to promote differentiation of adipose-derived stem cells into cardiomyocytes. [PDF]

Mol Biol Rep
Alshammari H, Abuhaimed J, Alshehri S, Siyal A, Shaheen S, Al-Saud SA.   +5 more
europepmc   +1 more source

Ivabradine Preserves Cardiac Structure and Reduces Cell Death in Four Dogs With Preclinical Mitral Valve Disease. [PDF]

Vet Med Sci
Pirintr P, Limprasutr V, Rungsipipat A, Rattanapinyopituk K, Sawangkoon S, Saengklub N, Kijtawornrat A.   +6 more
europepmc   +1 more source

HCN2 channels: a potential therapeutic target for orofacial neuropathic pain after trigeminal nerve injury. [PDF]

J Oral Facial Pain Headache
Yamamoto T, Ujita T, Sato-Yamada Y, Ichiki T, Kishimoto N, Terunuma M, Seo K.   +6 more
europepmc   +1 more source

Ivabradine in acute care: Revisiting the funny current in critical care context. [PDF]

World J Crit Care Med
Mukesh A, Sharma A, Kothari N.
europepmc   +1 more source

Optimal Heart Rate Modulation Therapy Using Ivabradine in Individuals With Acute Heart Failure. [PDF]

Clin Cardiol
Kataoka N, Imamura T.
europepmc   +1 more source

Efficacy of ivabradine in heart rate reduction after cardiac transplantation: Systematic review and meta-analysis. [PDF]

World J Cardiol
Ahmed F, Ali R, Haider F, Shah HH, Farhan K, Jahangir K, Kiyani M, Khan MS, Afzaal Z, Khan SI, Nizam MA, Usman M, Gohar N, Ahmed M, Mirza TR, Sattar Y, Taha A, Almendral J, Alenezi F.   +18 more
europepmc   +1 more source